Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune disease. Our pipeline targets SIK3 to deliver transformative therapies where unmet need remains high.
Investors 1
| Date | Name | Website |
| 10.07.2026 | Sofinnova ... | sofinnova.... |
Mentions in press and media 1
| Date | Title | Description |
| 29.04.2026 | Coultreon Biopharma Raises $125 Million Series A to Advance Oral Autoimmune Therapy | Coultreon Biopharma, a Belgium-based biotechnology company formerly known as Onco3R Therapeutics, has closed an oversubscribed 125 million dollar Series A financing round to advance its immunology pipeline. The round was led by Sofinnova In... |